CLDN6 and breast cancer: In addition to the altered nucleotide, amino acid, and lipid metabolism, we also observed that lactate, a glycolytic by–product, was altered upon CLDN6 overexpression in Figure 3H. In terms of metabolic plasticity, we wanted to investigate whether CLDN6 regulated aerobic glycolysis in breast cancer cells.